Physician profile
Akil Benjamin
NPI 1558573477
$6,618.77
in general payments reported to CMS, 2019-2025
34 companies · $1,282 in 2025
The $1,282 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,143 · 2020: $741 · 2021: $766 · 2022: $517 · 2023: $1,141 · 2024: $1,030 · 2025: $1,282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,452.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,683.59 | 2019-2025 | Proclaim, Eterna, Octrode |
| Nevro Corp. | $845.28 | 2019-2024 | Senza |
| Globus Medical, INC. | $503.47 | 2025 | Senza, Vyrsa V1 |
| Boston Scientific Corporation | $489.60 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Collegium Pharmaceutical, INC. | $416.01 | 2019-2025 | Xtampza, Belbuca |
| Saluda Medical Americas, INC. | $353.87 | 2024-2025 | Evoke |
| Medtronic, INC. | $325.41 | 2023-2025 | Intellis Adaptivestim |
| Vertos Medical, INC. | $305.98 | 2021-2024 | Mild Device Kit |
| Pfizer INC. | $261.48 | 2019-2025 | |
| Scilex Pharmaceuticals INC. | $217.18 | 2019-2020 | |
| Flowonix Medical Incorporated | $179.56 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $150.27 | 2020-2025 | Relistor |
| Si-Bone, INC. | $147.20 | 2019-2025 | |
| Electronic Waveform Lab, INC. | $107.35 | 2023-2025 | |
| Averitas Pharma INC. | $65.76 | 2023 | Qutenza |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $62.83 | 2023-2025 | Prospera, Biotronik |
| Novartis Pharmaceuticals Corporation | $62.60 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $48.08 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $45.20 | 2022 | |
| Lundbeck LLC | $42.87 | 2022 | |
| Medtronic USA, INC. | $39.68 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $34.79 | 2022-2023 | Seglentis |
| Daiichi Sankyo INC. | $33.99 | 2019 | |
| Horizon Therapeutics Plc | $28.43 | 2019 | |
| Tonix Medicines, INC. | $21.82 | 2025 | Tonmya |
| Amneal Pharmaceuticals LLC | $21.69 | 2023 | Lyvispah |
| Kaleo, INC. | $19.96 | 2019 | |
| Arbor Pharmaceuticals, INC. | $18.96 | 2020 | |
| Almatica Pharma LLC | $16.46 | 2022 | |
| Depuy Synthes Sales INC. | $15.93 | 2019 | |
| Abbvie INC. | $14.70 | 2025 | |
| Biodelivery Sciences International, INC. | $14.65 | 2019 | |
| Allergan, INC. | $12.46 | 2019 | |
| Shionogi INC | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akil Benjamin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.